期刊文献+

乌拉地尔与硝普钠治疗顽固性心力衰竭的对比研究 被引量:4

The comparative study of sodium nitroprusside and urapidil for treatment of the stubborn heart failure
在线阅读 下载PDF
导出
摘要 目的观察乌拉地尔与硝普钠治疗顽固性心力衰竭的疗效。方法对72例顽固性心力衰竭患者在综合治疗的基础上分别应用硝普钠(36例)与乌拉地尔治疗(36例)。疗程7—10d。结果乌拉地尔组总有效率(88.6%)显著高于硝普钠组(80%);两组治疗前后的脑钠肽(BNP)、心功能状况、血压及心率、呼吸频率均可得到明显的改善。但乌拉地尔可以更明显地改善心功能。结论在综合治疗的基础上应用乌拉地尔治疗顽固性心力衰竭。较硝普钠更明显地改善心功能,且具有更高的临床有效率,无明显的毒副作用。 Objective To compare the effects between sodium nitroprusside(SNP) and urapidil for treating the stubborn congestive heart failure. Methods Based on routine measure ,72 serious Chronic heart failure (CHF) patients were randomized into two groups ,36 to SNP group ,36 to urapidil group for 7 to 10 days. Results The total efficiency rate in urapidil group (88.6%) was more higher than in SNP group( 80% ). The index of heart function such as BNP,heart rate,respiratory rate and blood pressure improved in both groups after the therapy( P 〈0.05 ) ,but the effects in urapidil group was more obvious than in SNP group ( P 〈 0.01 ). Gonelusion Urapidil can be more efficient in treating stubborn congestive heart failure than SNP and has no more side effects.
出处 《内科》 2008年第4期498-499,共2页 Internal Medicine
关键词 乌拉地尔 硝普钠 顽固性心力衰竭 Urapidil Sodium nitroprusside Congestive heart failure
  • 相关文献

参考文献8

二级参考文献27

  • 1李天德 陈练 等.压宁定对充血性心力衰竭的血流动力学效应[J].北京医学,1995,17:40-40.
  • 2[1]Packer M.The neurohumoral hypothesis:a theory to explain the mechanism of disease progression in heart failure.J Am Coll Cardiol,1992,20:248-254
  • 3[2]Metra M,Nodari S,Aloia A,et al.A rationale for the use of β-blocker as standard treatment for heart failure.Am Heart J,2000,139:511-521
  • 4[3]Coh JN,Levine TB,Ohvari MT,et al.Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.N Eng J Med,1984,311:819-823
  • 5[4]Doughty RN,Whalley GA,Gamble G,et al.On behalf of the Australia/New Zealand Heart Failure Research Collaborative Group.Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease.J Am Coll Cardiol,1997,29:1060-1066
  • 6[5]Lechat PP,Packer M,Chalon S,et al.Clinical effects of β-adrenergic blockade in chronic heart failure:a meta-analysis of double-blind,placebo-controlled,randomised trials.Circulation,1998,98:1184-1191
  • 7[6]MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).Lancet,1999,353:2001-2007
  • 8[7]CIBIS-II Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II):a randomised trial.Lancet,1999,353:9-13
  • 9[8]Packer M.On behalf of the COPERNICUS investigators.Results of the COPERNICUS Study.Data presented at the 73rd Meeting of the American Heart Association.New Orleans,2000
  • 10[9]Parcker M,Coats AJS,Fowler MB,et al.The effect of carvedilol on morbidity and mortality in severe chronic heart failure.N Eng J Med,2001,344:1349-1355

共引文献113

同被引文献17

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部